NDAINHALATIONLIQUID
Approved
Aug 1972
Lifecycle
LOE Approaching
Competitive Pressure
30/100
Data completeness
1/8 — Limited
Drug data last refreshed 10h ago · AI intelligence enriched 2w ago
AI summarySynthesized from FDA + DailyMed + ClinicalTrials.gov data
ETHRANE (enflurane) is an inhalational volatile anesthetic liquid used for induction and maintenance of general anesthesia. It is administered via inhalation during surgical procedures and anesthesia management. The drug works as a central nervous system depressant to produce unconsciousness and anesthesia.
LOE Approaching
As a mature product approaching loss of exclusivity with moderate competitive pressure, the brand team is likely small and focused on lifecycle extension or managed decline strategies.
Mechanism of Action
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indications
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Career Relevance
Working on ETHRANE in its LOE-approaching stage offers limited growth but strong operational and regulatory expertise opportunities. Roles focus on maximizing profitability, managing portfolio transition, and ensuring compliance in a stable, mature market.
Supply Chain ManagerRegulatory Affairs Specialist
Worked on ETHRANE at Baxter International? Share your interview experience or compensation data (+7 days Pro)
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.